Nuvation Bio Inc. (NUVB)
Largest Insider Buys in Sector
NUVB Stock Price History Chart
NUVB Stock Performance
About Nuvation Bio Inc.
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation; NUV-569, a differentiated oral small molecule selective inhibitor of the Wee1 kinase for DNA damage repair; NUV-1182, an adenosine receptor inhibitor; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as PARP inhibitor to address ER+ breast and ovarian cancer. The company was formerly known as RePharmation Inc. and changed its name to Nuvation Bio Inc. in April 2019. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.
Insider Activity of Nuvation Bio Inc.
Over the last 12 months, insiders at Nuvation Bio Inc. have bought $9.51M and sold $0 worth of Nuvation Bio Inc. stock.
On average, over the past 5 years, insiders at Nuvation Bio Inc. have bought $8.16M and sold $33.18M worth of stock each year.
Highest buying activity among insiders over the last 12 months: NODELMAN OLEG (director) — $13.38M. Cui Xiangmin (director) — $2.32M. BLICKENSTAFF KIM D (director) — $1.5M.
The last purchase of 277,895 shares for transaction amount of $825,348 was made by Cui Xiangmin (director) on 2024‑06‑25.
List of Insider Buy and Sell Transactions, Nuvation Bio Inc.
| 2024-06-25 | Cui Xiangmin | director | 277,895 0.1098% | $2.97 | $825,348 | +0.67% | ||
| 2024-06-24 | Cui Xiangmin | director | 336,874 0.1354% | $2.98 | $1M | +1.33% | ||
| 2024-06-21 | Cui Xiangmin | director | 75,411 0.0321% | $3.00 | $226,233 | -0.98% | ||
| 2024-06-20 | Cui Xiangmin | director | 87,715 0.0372% | $2.99 | $262,268 | +0.33% | ||
| 2024-06-11 | BLICKENSTAFF KIM D | director | 172,189 0.071% | $2.90 | $500,089 | +5.26% | ||
| 2023-09-21 | NODELMAN OLEG | director | 53,000 0.0243% | $1.36 | $72,138 | +22.48% | ||
| 2023-09-20 | NODELMAN OLEG | director | 117,100 0.0542% | $1.36 | $159,490 | +25.93% | ||
| 2023-09-19 | NODELMAN OLEG | director | 5.14M 2.2462% | $1.26 | $6.46M | +28.60% | ||
| 2023-02-21 | NODELMAN OLEG | director | 53,000 0.016% | $1.36 | $72,138 | -20.39% | ||
| 2023-02-20 | NODELMAN OLEG | director | 117,100 0.0339% | $1.36 | $159,490 | -20.39% | ||
| 2023-02-19 | NODELMAN OLEG | director | 5.14M 1.3737% | $1.26 | $6.46M | -20.39% | ||
| 2022-12-05 | FALBERG KATHRYN E | director | 43,000 0.02% | $1.95 | $83,962 | -12.37% | ||
| 2022-12-02 | FALBERG KATHRYN E | director | 47,000 0.0215% | $1.98 | $93,187 | -15.00% | ||
| 2022-12-01 | FALBERG KATHRYN E | director | 84,959 0.0391% | $1.97 | $167,599 | -14.14% | ||
| 2022-11-30 | FALBERG KATHRYN E | director | 75,041 0.0336% | $1.85 | $139,088 | -10.73% | ||
| 2022-04-05 | Sale | Omega Fund V GP Manager, Ltd. | 2.5M 1.1241% | $5.60 | $14M | -59.30% | ||
| 2021-12-15 | Sale | Omega Fund V, L.P. | 10 percent owner | 500,000 0.2537% | $10.07 | $5.04M | -64.26% | |
| 2021-12-07 | Sale | Omega Fund V, L.P. | 10 percent owner | 1.4M 0.726% | $9.80 | $13.72M | -61.57% | |
| 2021-11-24 | NODELMAN OLEG | director | 185,026 0.0927% | $7.69 | $1.42M | -49.16% | ||
| 2021-11-23 | Sale | Omega Fund V, L.P. | 10 percent owner | 36 <0.0001% | $9.75 | $351 | -57.14% |
Insider Historical Profitability
| NODELMAN OLEG | director | 12674775 5.789% | $2.99 | 12 | 2 | <0.0001% |
| Cui Xiangmin | director | 2453131 0.9925% | $2.99 | 4 | 0 | |
| BLICKENSTAFF KIM D | director | 172189 0.0697% | $2.99 | 1 | 0 | |
| Omega Fund V, L.P. | 10 percent owner | 22957340 10.4855% | $2.99 | 0 | 7 | |
| Omega Fund V GP Manager, Ltd. | 20457340 9.3436% | $2.99 | 0 | 1 | ||
| EcoR1 Panacea Holdings, LLC | 390000 0.1781% | $2.99 | 1 | 0 | ||
| FALBERG KATHRYN E | director | 250000 0.1142% | $2.99 | 4 | 0 | <0.0001% |
| Bazemore Robert B | director | 5000 0.0023% | $2.99 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Fidelity Investments | $100.96M | 11.22 | 27.74M | +6.15% | +$5.85M | 0.01 | |
| Ecor1 Capital Llc | $69.92M | 7.77 | 19.21M | 0% | +$0 | 1.78 | |
| Omega Fund Management Llc | $51.22M | 5.69 | 14.07M | -6.63% | -$3.64M | 37.97 | |
| BlackRock | $45.61M | 5.07 | 12.53M | -2.74% | -$1.29M | <0.01 | |
| The Vanguard Group | $27.42M | 3.05 | 7.53M | +3% | +$799,100.13 | <0.01 | |
| Abrams Capital | $13.87M | 1.54 | 3.81M | 0% | +$0 | 0.43 | |
| Tang Capital Management, LLC | $12.93M | 1.44 | 3.55M | +1.48% | +$188,784.96 | 0.05 | |
| Geode Capital Management | $11.38M | 1.27 | 3.13M | +2.65% | +$294,412.64 | <0.01 | |
| State Street | $11.08M | 1.23 | 3.04M | -0.61% | -$68,082.56 | <0.0001 | |
| Redmile Group | $11.03M | 1.23 | 3.03M | 0% | +$0 | 0.41 | |
| Aisling Capital Management LP | $9.25M | 1.03 | 2.54M | 0% | +$0 | 3.17 | |
| Citadel Advisors LLC | $7.64M | 0.85 | 2.1M | -29.48% | -$3.19M | 0.01 | |
| Barclays | $5.84M | 0.65 | 1.61M | +229.88% | +$4.07M | <0.01 | |
| Octagon Capital Advisors LP | $5M | 0.56 | 1.37M | +37.49% | +$1.36M | 0.66 | |
| T. Rowe Price | $4.93M | 0.55 | 1.35M | +551.77% | +$4.18M | <0.01 | |
| Awm Investment Company Inc | $4.91M | 0.55 | 1.35M | 0% | +$0 | 0.73 | |
| Sio Capital Management LLC | $4.86M | 0.54 | 1.34M | New | +$4.86M | 1.72 | |
| EDBI Pte Ltd | $4.62M | 0.51 | 1.27M | 0% | +$0 | 5.24 | |
| Northern Trust | $4.48M | 0.5 | 1.23M | +0.91% | +$40,404.00 | <0.01 | |
| Morgan Stanley | $4.3M | 0.48 | 1.18M | +47.23% | +$1.38M | <0.0001 | |
| Acadian Asset Management | $4.27M | 0.48 | 1.17M | +81.86% | +$1.92M | 0.02 | |
| Two Sigma | $4.2M | 0.47 | 1.15M | -23.69% | -$1.3M | 0.01 | |
| Charles Schwab | $4.18M | 0.46 | 1.15M | +1.9% | +$77,764.96 | <0.01 | |
| Goldman Sachs | $4.15M | 0.46 | 1.14M | +43.53% | +$1.26M | <0.01 | |
| Two Sigma Advisers LP | $3.71M | 0.41 | 1.02M | -11.19% | -$467,012.00 | 0.01 | |
| Renaissance Technologies | $3.55M | 0.39 | 974,700 | -34.28% | -$1.85M | 0.01 | |
| Millennium Management LLC | $3.29M | 0.37 | 904,290 | -70.78% | -$7.97M | <0.01 | |
| Nuveen | $3.19M | 0.35 | 875,362 | +114.19% | +$1.7M | <0.01 | |
| D. E. Shaw & Co. | $3.13M | 0.35 | 860,940 | +67.2% | +$1.26M | <0.01 | |
| Palo Alto Investors Lp | $2.81M | 0.31 | 772,652 | New | +$2.81M | 0.32 | |
| Jacobs Levy Equity Management | $2.73M | 0.3 | 748,793 | +254.07% | +$1.96M | 0.01 | |
| Citigroup | $2.57M | 0.29 | 705,405 | -33.2% | -$1.28M | <0.01 | |
| Ikarian Capital LLC | $2.31M | 0.26 | 633,282 | -48.21% | -$2.15M | 0.66 | |
| Assenagon Asset Management S.A. | $2.09M | 0.23 | 574,410 | -22.25% | -$598,492.32 | 0.01 | |
| Acuitas Investments, LLC | $1.96M | 0.22 | 537,317 | +16.69% | +$279,719.46 | 1.03 | |
| BNY Mellon | $1.71M | 0.19 | 469,394 | -9.4% | -$177,304.49 | <0.0001 | |
| Clearline Capital LP | $1.59M | 0.18 | 437,237 | -11.58% | -$208,459.20 | 0.16 | |
| UBS | $1.54M | 0.17 | 423,802 | +11.14% | +$154,638.09 | <0.0001 | |
| Connor Clark & Lunn Investment Management Ltd | $1.39M | 0.16 | 382,180 | +30.13% | +$322,056.23 | <0.01 | |
| Bank of America | $1.33M | 0.15 | 365,326 | -24.36% | -$428,224.28 | <0.0001 | |
| Federated Hermes | $1.31M | 0.15 | 360,844 | +0.33% | +$4,269.72 | <0.01 | |
| Invesco | $1.17M | 0.13 | 322,014 | +38.13% | +$323,566.89 | <0.0001 | |
| Man Group Plc | $947,416.00 | 0.11 | 260,279 | +9.21% | +$79,894.40 | <0.01 | |
| Prosight Management Lp | $910,000.00 | 0.1 | 250,000 | -87.81% | -$6.55M | 0.25 | |
| Intellectus Partners | $853,362.00 | 0.1 | 234,440 | +29.44% | +$194,077.61 | 0.23 | |
| Ameriprise Financial | $851,869.00 | 0.1 | 234,030 | +215.28% | +$581,679.14 | <0.0001 | |
| Eam Investors | $815,546.00 | 0.09 | 224,051 | New | +$815,546.00 | 0.13 | |
| Panagora | $772,091.00 | 0.09 | 212,113 | New | +$772,091.00 | <0.01 | |
| RhumbLine Advisers | $755,473.00 | 0.08 | 207,550 | -1.31% | -$9,998.96 | <0.01 | |
| Dimensional Fund Advisors | $719,482.00 | 0.08 | 197,660 | +367.97% | +$565,735.77 | <0.0001 |